Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C17H25N3O4S |
| Molecular Weight | 367.463 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1C(=O)NCC2CCCN2CC3CC3)S(N)(=O)=O
InChI
InChIKey=BTYDXWCTJDAEHA-UHFFFAOYSA-N
InChI=1S/C17H25N3O4S/c1-24-16-7-6-14(25(18,22)23)9-15(16)17(21)19-10-13-3-2-8-20(13)11-12-4-5-12/h6-7,9,12-13H,2-5,8,10-11H2,1H3,(H,19,21)(H2,18,22,23)
| Molecular Formula | C17H25N3O4S |
| Molecular Weight | 367.463 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7197651
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7197651
Cipropride is an anti-emetic drug of the substituted benzamide class. It was discovered by Synthelabo in the early 1980s. The drug acts by blocking the dopamine receptor and thus affecting the chemo-receptor trigger zone for vomiting. Clinical trials showed that cipropride was effective for the prevention of nausea and vomiting induced by cytotoxic chemotherapy agents dacarbazine and Cis-platinum. The subsequent development of the drug was not reported.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0004952 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7197651 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:24:26 GMT 2025
by
admin
on
Mon Mar 31 18:24:26 GMT 2025
|
| Record UNII |
0D2VUO6DCN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C267
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
68878
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
C032468
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
C78026
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
100000081541
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
DTXSID20988119
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104151
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
SUB07472MIG
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
4655
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
0D2VUO6DCN
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY | |||
|
68475-40-1
Created by
admin on Mon Mar 31 18:24:26 GMT 2025 , Edited by admin on Mon Mar 31 18:24:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |